Intrinsic Value of S&P & Nasdaq Contact Us

Artelo Biosciences, Inc. ARTL NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ARTL

Artelo Biosciences, Inc. (ARTL) has a market capitalization of $11.28M and trades at $5.31. The 52-week range is 2.955-85.8.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1, Earnings Per Share (EPS) of $-5.47.

The stock has a beta of 0.41, operates in the Healthcare sector.

Trading Data
Current Price$5.31
52-Week Range2.955-85.8
Volume157.39K
Avg Volume (30D)2.92M
Market Cap$11.28M
Beta (1Y)0.41
Company
IPO Date2019-06-21
Employees6
CEOGregory D. Gorgas
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS04301G7060
CUSIP04301G706
Income (Latest Year)
EBITDA$-12.54M
Operating Income$-11.4M
Net Income$-12.88M
EPS$-5.47
EPS Diluted$-5.47
Shares Outstanding$2.36M
Balance Sheet (Latest Year)
Total Assets$2.8M
Current Assets$695K
Cash & ST Investments$600K
Total Liabilities$4.07M
Total Debt$693K
Net Debt$93K
Total Equity$-1.27M
Debt / Equity-0.54
Valuation Ratios
P/E Ratio-1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message